Menu
Back to User profile » Dr Christopher Ambrose
Papers published by Dr Christopher Ambrose:
Tezepelumab for Severe Asthma: One Drug Targeting Multiple Disease Pathways and Patient Types
Panettieri R Jr, Lugogo N, Corren J, Ambrose CS
Journal of Asthma and Allergy 2024, 17:219-236
Published Date: 19 March 2024
Effect of Biologic Therapies on Airway Hyperresponsiveness and Allergic Response: A Systematic Literature Review
Spahn JD, Brightling CE, O’Byrne PM, Simpson LJ, Molfino NA, Ambrose CS, Martin N, Hallstrand TS
Journal of Asthma and Allergy 2023, 16:755-774
Published Date: 21 July 2023
Long-Term Use of Maintenance Systemic Corticosteroids is Associated with Multiple Adverse Conditions in a Large, Real-World Cohort of US Adults with Severe Asthma
Lugogo N, Chipps BE, Panettieri RA Jr, Trudo F, Ambrose CS
Journal of Asthma and Allergy 2022, 15:1753-1761
Published Date: 7 December 2022
Impact of the COVID-19 Pandemic on Incidence of Asthma Exacerbations and Hospitalizations in US Subspecialist-Treated Patients with Severe Asthma: Results from the CHRONICLE Study
Moore WC, Ledford DK, Carstens DD, Ambrose CS
Journal of Asthma and Allergy 2022, 15:1195-1203
Published Date: 31 August 2022
Real World Biologic Use and Switch Patterns in Severe Asthma: Data from the International Severe Asthma Registry and the US CHRONICLE Study
Menzies-Gow AN, McBrien C, Unni B, Porsbjerg CM, Al-Ahmad M, Ambrose CS, Dahl Assing K, von Bülow A, Busby J, Cosio BG, FitzGerald JM, Garcia Gil E, Hansen S, Heaney LG, Hew M, Jackson DJ, Kallieri M, Loukides S, Lugogo NL, Papaioannou AI, Larenas-Linnemann D, Moore WC, Perez-de-Llano LA, Rasmussen LM, Schmid JM, Siddiqui S, Alacqua M, Tran TN, Suppli Ulrik C, Upham JW, Wang E, Bulathsinhala L, Carter VA, Chaudhry I, Eleangovan N, Murray RB, Price CA, Price DB
Journal of Asthma and Allergy 2022, 15:63-78
Published Date: 13 January 2022
Health-Related Quality of Life and Productivity Among US Patients with Severe Asthma
Soong W, Chipps BE, O'Quinn S, Trevor J, Carr WW, Belton L, Trudo F, Ambrose CS
Journal of Asthma and Allergy 2021, 14:713-725
Published Date: 25 June 2021
The CHRONICLE Study of US Adults with Subspecialist-Treated Severe Asthma: Objectives, Design, and Initial Results
Ambrose CS, Chipps BE, Moore WC, Soong W, Trevor J, Ledford DK, Carr WW, Lugogo N, Trudo F, Tran TN, Panettieri RA Jr
Pragmatic and Observational Research 2020, 11:77-90
Published Date: 16 July 2020
Patient and physician preferences for attributes of biologic medications for severe asthma
Gelhorn HL, Balantac Z, Ambrose CS, Chung YN, Stone B
Patient Preference and Adherence 2019, 13:1253-1268
Published Date: 25 July 2019